Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,070 | -7,164 | -1,847 | -4,450 | -3,024 |
| Depreciation Amortization | 10 | 5 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 914 | 595 | 450 | 64 | 838 |
| Other Working Capital | 539 | 411 | -442 | -200 | 285 |
| Other Operating Activity | 636 | 319 | -315 | 6 | -835 |
| Operating Cash Flow | $-10,971 | $-5,834 | $-2,154 | $-4,580 | $-2,736 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124 | -111 | -17 | 0 | N/A |
| Purchase Of Investment | -58,624 | 0 | 0 | N/A | N/A |
| Investing Cash Flow | $-58,748 | $-111 | $-17 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 78,374 | 86,250 | 0 | N/A | 0 |
| Other Financing Activity | 20,993 | 14,181 | 20,993 | 12,710 | 2,605 |
| Financing Cash Flow | $99,367 | $100,431 | $20,993 | $12,710 | $2,605 |
| Beginning Cash Position | 8,663 | 8,663 | 8,663 | 520 | 527 |
| End Cash Position | 38,311 | 103,149 | 27,485 | 8,660 | 396 |
| Net Cash Flow | $29,648 | $94,486 | $18,822 | $8,130 | $-131 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,971 | -5,834 | -2,154 | -4,580 | -2,736 |
| Capital Expenditure | -124 | -111 | -17 | N/A | N/A |
| Free Cash Flow | -11,095 | -5,945 | -2,171 | -4,580 | -2,736 |